1. Home
  2. DNLI vs AIR Comparison

DNLI vs AIR Comparison

Compare DNLI & AIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • AIR
  • Stock Information
  • Founded
  • DNLI 2013
  • AIR 1951
  • Country
  • DNLI United States
  • AIR United States
  • Employees
  • DNLI N/A
  • AIR 5700
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • AIR Aerospace
  • Sector
  • DNLI Health Care
  • AIR Industrials
  • Exchange
  • DNLI Nasdaq
  • AIR Nasdaq
  • Market Cap
  • DNLI 2.1B
  • AIR 2.4B
  • IPO Year
  • DNLI 2017
  • AIR 1988
  • Fundamental
  • Price
  • DNLI $14.21
  • AIR $69.01
  • Analyst Decision
  • DNLI Strong Buy
  • AIR Strong Buy
  • Analyst Count
  • DNLI 15
  • AIR 6
  • Target Price
  • DNLI $33.85
  • AIR $80.67
  • AVG Volume (30 Days)
  • DNLI 1.7M
  • AIR 275.6K
  • Earning Date
  • DNLI 07-31-2025
  • AIR 07-17-2025
  • Dividend Yield
  • DNLI N/A
  • AIR N/A
  • EPS Growth
  • DNLI N/A
  • AIR N/A
  • EPS
  • DNLI N/A
  • AIR N/A
  • Revenue
  • DNLI N/A
  • AIR $2,682,500,000.00
  • Revenue This Year
  • DNLI N/A
  • AIR $18.46
  • Revenue Next Year
  • DNLI $335.74
  • AIR $5.10
  • P/E Ratio
  • DNLI N/A
  • AIR N/A
  • Revenue Growth
  • DNLI N/A
  • AIR 21.07
  • 52 Week Low
  • DNLI $10.57
  • AIR $46.51
  • 52 Week High
  • DNLI $33.33
  • AIR $76.34
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 49.63
  • AIR 64.93
  • Support Level
  • DNLI $13.41
  • AIR $68.16
  • Resistance Level
  • DNLI $14.66
  • AIR $70.28
  • Average True Range (ATR)
  • DNLI 0.63
  • AIR 1.43
  • MACD
  • DNLI -0.03
  • AIR -0.16
  • Stochastic Oscillator
  • DNLI 40.82
  • AIR 64.72

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About AIR AAR Corp.

AAR Corp is engaged in providing products and services to aviation, government, and defense market. It operates in three segments namely Parts Supply, Repair & Engineering, and Integrated Solutions. The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts. Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services. Integrated Solutions segment majorly consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense and foreign governments, flight hour component inventory and repair programs for commercial airlines.

Share on Social Networks: